Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urocortin 2 for acute decompensated heart failure
ACTRN12609000508279Phase 2Completed
- Sponsor
- Health Research Council of New Zealand
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in heart failure (HF) comparing Conventional treatment plus urocortin 2 with Conventional treatment plus placebo (2 arms). Primary endpoint: Change in neurohormonal status. Started Oct 2009; status: completed.
02
Drugs
urocortin-2
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12609000508279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000508279.